Shutterstock
Cornell Stamoran, Vice President, Strategy and Government Affairs and Matt Mollan, Vice President Operations at Catalent for our latest EPM Magazine issue.
The Complexities of Manufacturing Orphan Drugs in Product Development
Cornell Stamoran, Vice President, Strategy and Government Affairs, Catalent and Matt Mollan, Vice President Operations at Catalent explore the complexities of manufacturing orphan drugs in product development for our EPM Magazine.
Published:
|
5 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.